BGM Group Ltd. (NASDAQ:BGM) Sees Significant Decrease in Short Interest

BGM Group Ltd. (NASDAQ:BGM) was the recipient of a large decrease in short interest in April. As of April 15th, there was short interest totaling 40,252 shares, a decrease of 61.2% from the March 31st total of 103,777 shares. Based on an average trading volume of 330,989 shares, the short-interest ratio is currently 0.1 days. Currently, 0.1% of the company’s shares are short sold.

BGM Group Stock Up 1.5%

BGM stock opened at $0.33 on Friday. The business’s 50-day moving average is $0.69 and its two-hundred day moving average is $4.22. BGM Group has a 1 year low of $0.27 and a 1 year high of $17.17.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of BGM Group in a research note on Monday, April 20th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, BGM Group currently has a consensus rating of “Sell”.

Institutional Investors Weigh In On BGM Group

Several hedge funds and other institutional investors have recently made changes to their positions in BGM. Geode Capital Management LLC acquired a new stake in shares of BGM Group during the 2nd quarter worth about $412,000. Marshall Wace LLP acquired a new stake in shares of BGM Group during the 2nd quarter worth about $218,000. Finally, Mariner LLC acquired a new stake in shares of BGM Group during the 3rd quarter worth about $267,000.

BGM Group Company Profile

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.